ATE147759T1 - Verfahren und materialien zum nachweis und therapie von hiv - Google Patents

Verfahren und materialien zum nachweis und therapie von hiv

Info

Publication number
ATE147759T1
ATE147759T1 AT91202465T AT91202465T ATE147759T1 AT E147759 T1 ATE147759 T1 AT E147759T1 AT 91202465 T AT91202465 T AT 91202465T AT 91202465 T AT91202465 T AT 91202465T AT E147759 T1 ATE147759 T1 AT E147759T1
Authority
AT
Austria
Prior art keywords
antibodies
hiv
monoclonal
reactive
disclosed
Prior art date
Application number
AT91202465T
Other languages
English (en)
Inventor
Tsuneya Ohno
Original Assignee
Nissin Food Products Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Nissin Food Products Ltd filed Critical Nissin Food Products Ltd
Application granted granted Critical
Publication of ATE147759T1 publication Critical patent/ATE147759T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C07K16/42—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against immunoglobulins
    • C07K16/4208—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against immunoglobulins against an idiotypic determinant on Ig
    • C07K16/4241—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against immunoglobulins against an idiotypic determinant on Ig against anti-human or anti-animal Ig
    • C07K16/4258—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against immunoglobulins against an idiotypic determinant on Ig against anti-human or anti-animal Ig against anti-receptor Ig
    • C07K16/4275—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against immunoglobulins against an idiotypic determinant on Ig against anti-human or anti-animal Ig against anti-receptor Ig against anti-CD4 Ig
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2740/00—Reverse transcribing RNA viruses
    • C12N2740/00011—Details
    • C12N2740/10011—Retroviridae
    • C12N2740/16011—Human Immunodeficiency Virus, HIV
    • C12N2740/16111—Human Immunodeficiency Virus, HIV concerning HIV env
    • C12N2740/16122—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biophysics (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Immunology (AREA)
  • Biochemistry (AREA)
  • Virology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
AT91202465T 1987-02-19 1988-02-18 Verfahren und materialien zum nachweis und therapie von hiv ATE147759T1 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US1628287A 1987-02-19 1987-02-19
US6406687A 1987-06-29 1987-06-29
US14637188A 1988-02-03 1988-02-03

Publications (1)

Publication Number Publication Date
ATE147759T1 true ATE147759T1 (de) 1997-02-15

Family

ID=27360536

Family Applications (2)

Application Number Title Priority Date Filing Date
AT88301369T ATE106945T1 (de) 1987-02-19 1988-02-18 Methoden und materialien für die hiv-erkennung und therapie.
AT91202465T ATE147759T1 (de) 1987-02-19 1988-02-18 Verfahren und materialien zum nachweis und therapie von hiv

Family Applications Before (1)

Application Number Title Priority Date Filing Date
AT88301369T ATE106945T1 (de) 1987-02-19 1988-02-18 Methoden und materialien für die hiv-erkennung und therapie.

Country Status (5)

Country Link
EP (2) EP0468601B1 (de)
JP (1) JP2583555B2 (de)
AT (2) ATE106945T1 (de)
AU (1) AU609447B2 (de)
DE (2) DE3855761T2 (de)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL93599A0 (en) * 1989-03-03 1990-12-23 Microgenesys Inc Kit and/or composition for the prevention or treatment of aids
AP237A (en) * 1990-05-29 1993-04-29 Cedars Sinai Medical Center Immunoreagents reactive with a conserved epitope of human immunodeficiency virus type 1 (HIV-1) gp120 and methods of use.
CA2111681A1 (en) * 1991-06-19 1992-12-23 Malcolm L. Gefter Mimic peptides of gp120
EP0771326A4 (de) * 1994-07-13 2002-01-16 Progenics Pharm Inc Gegenstände zur entfernung von hiv-1 aus einer probe und verfahren zu ihrer verwendung
CN1307640A (zh) * 1998-05-25 2001-08-08 旭化成株式会社 细胞分离装置和分离方法
CN112362864B (zh) * 2021-01-12 2021-04-30 广州科方生物技术股份有限公司 一种降低免疫诊断试剂背景发光值的处理剂及其制备方法

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8423659D0 (en) * 1984-09-19 1984-10-24 Pasteur Institut Cloned dna sequences
US4652599A (en) * 1984-04-23 1987-03-24 The United States Of America As Represented By The Department Of Health And Human Services Method of continuous production of retroviruses (HTLV-III) from patients with AIDS and pre-AIDS using permissive cells
FR2580177B2 (fr) * 1985-04-15 1989-06-02 Pasteur Institut Antigenes apparentes a la glycoproteine d'enveloppe du virus du sida, notamment precurseurs de cette glycoproteine, procedes d'obtention de ces antigenes et moyens mis en oeuvre dans ces procedes, applications de ces antigenes a la preparation de compositions immunogenes ou pour le diagnostic du sida ou des affections qui lui sont apparentees
DK152517B (da) * 1985-08-21 1988-03-07 Nordisk Gentofte Fremgangsmaade til paavisning af infektioes aids-virus
DK155886D0 (da) * 1986-04-04 1986-04-04 Bo Arne Hofmann Vaccine og fremgangsmaade til fremstilling af denne
AU7780687A (en) * 1986-07-23 1988-02-10 Aphton Corp. Immunogens and improved methods of making immunogens
JP3134874B2 (ja) * 1986-08-21 2001-02-13 ザ・トラステイーズ・オブ・コロンビア・ユニヴアーシテイ・イン・ザ・シテイ・オブ・ニユー・ヨーク Ｔ細胞表面タンパク質ｔ４をコードするｄｎａ並びにｔ４フラグメントのａｉｄｓ治療への使用
AU620804B2 (en) * 1987-03-23 1992-02-27 Hiver Limited Novel vaccines

Also Published As

Publication number Publication date
JPS63294795A (ja) 1988-12-01
ATE106945T1 (de) 1994-06-15
EP0280468A3 (en) 1990-09-05
AU1190388A (en) 1988-09-01
JP2583555B2 (ja) 1997-02-19
DE3855761T2 (de) 1997-06-05
DE3855761D1 (de) 1997-02-27
EP0468601B1 (de) 1997-01-15
DE3889945D1 (de) 1994-07-14
EP0280468B1 (de) 1994-06-08
EP0280468A2 (de) 1988-08-31
DE3889945T2 (de) 1995-01-19
EP0468601A1 (de) 1992-01-29
AU609447B2 (en) 1991-05-02

Similar Documents

Publication Publication Date Title
EP0751992A4 (de) Vaskularer endothelialer wachstumsfaktor 2
ATE132197T1 (de) Monoklonale antikörper
AR243931A1 (es) Antigeno purificado,conjunto de reactivos para la deteccion de anticuerpos anti-hiv-2 en un fluido biologico que comprende dichos antigenos,anticuerpos,hibridomas y procedimientos.
DE3852054D1 (de) Monoklonale Antikörper gegen Glycolipid-Antigene und ihre Verwendung.
LU91237I2 (fr) Palifermin et ses dérivés pharmaceutiquement acceptables (kepivance)
ATE107663T1 (de) Synthetische peptidantigene zum nachweis von htlv-1-infektionen.
ATE163766T1 (de) Synthetisches antigen zum nachweis von mit aids in zusammenhang stehenden krankheiten
KR890002547A (ko) Hiv 감염의 치료 및 진단용 모노클로날항체 및 펩티드
ATE109830T1 (de) Expression von virusproteinen mit immunologischer aktivität.
DK392387A (da) Monoklonalt antistrof til diagnostisk anvendelse og fremgangsmaade til fremstilling af et saadan antistof
EP0317804A3 (en) Hiv peptides and methods for detection of hiv
DE3855761D1 (de) Verfahren und Materialien zum Nachweis und Therapie von HIV
ATE73491T1 (de) Hybridomazellen und deren monoklonale antikoerper gegen den humanen pluropotenten granulozyten- kolonie stimulierenden faktor.
ES8505406A1 (es) Procedimiento de obtener y aislar hibridomas secretores de anticuerpos, procedimiento de obtener anticuerpos y metodo de obtener polipeptidos
FR2563630B1 (fr) Anticorps monoclonaux anticytomegalovirus et procedes pour le diagnostic in vitro des infections par les cytomegalovirus humains et d'une proteine-kinase inductible par les cytomegalovirus et susceptible d'etre reconnue par les susdits anticorps monoclonaux
AU608413B2 (en) Mouse monoclonal antibody (5-21-3) to human immunodeficiency virus gp41 protein
ATE105938T1 (de) Monoklonale antikörper gegen spezifische antigene regionen des humanen immundefizienzvirus und methoden zur verwendung.
ATE108664T1 (de) Verfahren zur verhütung von gvhd.
Ohashi et al. Monoclonal antibody to chicken fetal antigen on Marek's disease lymphoblastoid cell line MDCC-MSB1
FR2601037B1 (fr) Peptide presentant des proprietes antigeniques isole de la proteine 28 kd de s. mansoni et son procede d'isolement, anticorps monoclonaux reconnaissant au moins un epitope dudit peptide et application de celui-ci dans l'induction de la synthese d'anticorps neutralisants
BE899484A (fr) Nouveaux determinants antigeniques apparentes a l'adenocarcinome et anticorps qui leur sont specifiques.
DE59009676D1 (de) Verfahren zur Bestimmung von Antigenen und/oder Antikörpern in menschlichen Körperflüssigkeiten sowie Set zur Durchführung des Verfahrens.
SU1540269A1 (ru) Штамм гибридных культивируемых клеток животного mus musculus, используемый для получения моноклональных антител к поверхностному гликопротеину вирусов комплекса клещевого энцефалита
AU1508088A (en) Monoclonal antibodies to specific antigenic regions of the human immunodeficiency virus and methods for use
FI883765L (fi) Antikroppar mot biologiskt aktiva polypeptider och deras anvaendning vid diagnostiska foerfaranden.

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties